Long-term follow-up after bariatric surgery: a systematic review
- PMID: 25182102
- PMCID: PMC4409000
- DOI: 10.1001/jama.2014.10706
Long-term follow-up after bariatric surgery: a systematic review
Abstract
Importance: Bariatric surgery is an accepted treatment for obesity. Despite extensive literature, few studies report long-term follow-up in cohorts with adequate retention rates.
Objective: To assess the quality of evidence and treatment effectiveness 2 years after bariatric procedures for weight loss, type 2 diabetes, hypertension, and hyperlipidemia in severely obese adults.
Evidence review: MEDLINE and Cochrane databases were searched from 1946 through May 15, 2014. Search terms included bariatric surgery, individual bariatric procedures, and obesity. Studies were included if they described outcomes for gastric bypass, gastric band, or sleeve gastrectomy performed on patients with a body mass index of 35 or greater, had more than 2 years of outcome information, and had follow-up measures for at least 80% of the initial cohort. Two investigators reviewed each study and a third resolved study inclusion disagreements.
Findings: Of 7371 clinical studies reviewed, 29 studies (0.4%, 7971 patients) met inclusion criteria. All gastric bypass studies (6 prospective cohorts, 5 retrospective cohorts) and sleeve gastrectomy studies (2 retrospective cohorts) had 95% confidence intervals for the reported mean, median, or both exceeding 50% excess weight loss. This amount of excess weight loss occurred in 31% of gastric band studies (9 prospective cohorts, 5 retrospective cohorts). The mean sample-size-weighted percentage of excess weight loss for gastric bypass was 65.7% (n = 3544) vs 45.0% (n = 4109) for gastric band. Nine studies measured comorbidity improvement. For type 2 diabetes (glycated hemoglobin <6.5% without medication), sample-size-weighted remission rates were 66.7% for gastric bypass (n = 428) and 28.6% for gastric band (n = 96). For hypertension (blood pressure <140/90 mm Hg without medication), remission rates were 38.2% for gastric bypass ( n = 808) and 17.4% for gastric band (n = 247). For hyperlipidemia (cholesterol <200 mg/dL, high-density lipoprotein >40 mg/dL, low-density lipoprotein <160 mg/dL, and triglycerides <200 mg/dL), remission rates were 60.4% for gastric bypass (n = 477) and 22.7% for gastric band (n = 97).
Conclusions and relevance: Very few bariatric surgery studies report long-term results with sufficient patient follow-up to minimize biased results. Gastric bypass has better outcomes than gastric band procedures for long-term weight loss, type 2 diabetes control and remission, hypertension, and hyperlipidemia. Insufficient evidence exists regarding long-term outcomes for gastric sleeve resections.
Conflict of interest statement
Figures
Comment in
-
The current state of the evidence for bariatric surgery.JAMA. 2014 Sep 3;312(9):898-9. doi: 10.1001/jama.2014.10940. JAMA. 2014. PMID: 25182097 No abstract available.
-
Gastric bypass has better long-term outcomes than gastric banding.Evid Based Med. 2015 Feb;20(1):18. doi: 10.1136/ebmed-2014-110113. Epub 2014 Dec 16. Evid Based Med. 2015. PMID: 25516978 No abstract available.
Similar articles
-
Surgery for weight loss in adults.Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Free PMC article.
-
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Health Technol Assess. 2009. PMID: 19726018
-
Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature.Ann Surg. 2013 Jan;257(1):87-94. doi: 10.1097/SLA.0b013e31827b6c02. Ann Surg. 2013. PMID: 23235396 Clinical Trial.
-
Comparison of metabolic outcomes in patients undergoing laparoscopic roux-en-Y gastric bypass versus sleeve gastrectomy - a systematic review and meta-analysis of randomised controlled trials.Swiss Med Wkly. 2018 Jul 5;148:w14633. doi: 10.57187/smw.2018.14633. eCollection 2018. Swiss Med Wkly. 2018. PMID: 30035801
-
Prepregnancy Roux-en-Y gastric bypass vs sleeve gastrectomy: a systematic review, pairwise, and network meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2023 Jun;5(6):100914. doi: 10.1016/j.ajogmf.2023.100914. Epub 2023 Mar 7. Am J Obstet Gynecol MFM. 2023. PMID: 36889438
Cited by
-
Association of Roux-en-Y Gastric Bypass With Postoperative Health Care Use and Expenditures in Canada.JAMA Surg. 2020 Sep 1;155(9):e201985. doi: 10.1001/jamasurg.2020.1985. Epub 2020 Sep 16. JAMA Surg. 2020. PMID: 32697298 Free PMC article.
-
How to Choose the Best Metabolic Procedure?Curr Atheroscler Rep. 2016 Jul;18(7):43. doi: 10.1007/s11883-016-0590-5. Curr Atheroscler Rep. 2016. PMID: 27229936 Review.
-
Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Is Intrathoracic Migration of the Sleeve of High Incidence?Obes Surg. 2024 Aug;34(8):2907-2913. doi: 10.1007/s11695-024-07341-y. Epub 2024 Jul 8. Obes Surg. 2024. PMID: 38976187
-
Factors Associated with Recurrent Ulcers in Patients with Gastric Surgery after More Than 15 Years: A Cross-Sectional Single-Center Study.Gastroenterol Res Pract. 2018 Nov 4;2018:8319481. doi: 10.1155/2018/8319481. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 30524477 Free PMC article.
-
Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery.Gut Microbes. 2022 Jan-Dec;14(1):2031696. doi: 10.1080/19490976.2022.2031696. Gut Microbes. 2022. PMID: 35130127 Free PMC article.
References
-
- Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;(2):CD003641. - PubMed
-
- Graefen M. Low quality of evidence for robot-assisted laparoscopic prostatectomy: a problem not only in the robotic literature. Eur Urol. 2010;57(6):938–940. - PubMed
-
- Moher D, Liberati A, Tetzlaff J, Altman DG PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. - PubMed
-
- Body mass index table 1. National Heart, Lung, and Blood Institute; [Accessed July 29, 2014]. http://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmi_tbl.htm.
-
- Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–436. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous